Skip to main content
Top
Published in: International Journal of Hematology 2/2006

01-08-2006 | Case Report

Successful Treatment of Minimal Residual Disease—Positive Philadelphia Chromosome—Positive Acute Lymphoblastic Leukemia with Imatinib Followed by Reduced-Intensity Unrelated Cord Blood Transplantation after Allogeneic Peripheral Blood Stem Cell Transplantation

Authors: Akiyoshi Takami, Shigeru Shimadoi, Chiharu Sugimori, Kenichi Takemoto, Masami Shibayama, Tomotaka Yoshida, Tohru Murayama, Kenichi Nagai, Koichi Miyamura, Hidesaku Asakura, Shinji Nakao

Published in: International Journal of Hematology | Issue 2/2006

Login to get access
Metadata
Title
Successful Treatment of Minimal Residual Disease—Positive Philadelphia Chromosome—Positive Acute Lymphoblastic Leukemia with Imatinib Followed by Reduced-Intensity Unrelated Cord Blood Transplantation after Allogeneic Peripheral Blood Stem Cell Transplantation
Authors
Akiyoshi Takami
Shigeru Shimadoi
Chiharu Sugimori
Kenichi Takemoto
Masami Shibayama
Tomotaka Yoshida
Tohru Murayama
Kenichi Nagai
Koichi Miyamura
Hidesaku Asakura
Shinji Nakao
Publication date
01-08-2006
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2006
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.06066

Other articles of this Issue 2/2006

International Journal of Hematology 2/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine